Pancreatic Cancer Research

ResearcherTianjin Nankai HospitalActive in the last 2 years

Haibo Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7549-5613; OpenAlex author ID A5100328793. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling. Co-author DOI 10.1158/0008-5472.can-26-0333↗
  2. The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2023.e16150↗
  3. Expression and clinical significance of EGF and TGF-α in chronic pancreatitis and pancreatic cancer. Last author DOI 10.23736/s0391-1977.17.02721-3↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ning Pu · 1 shared paper, 2026 · strength 0.23
  2. Chaoyu Pang · 1 shared paper, 2026 · strength 0.23
  3. Hanlin Yin · 1 shared paper, 2026 · strength 0.23
  4. Qiangda Chen · 1 shared paper, 2026 · strength 0.23
  5. Taochen He · 1 shared paper, 2026 · strength 0.23
  6. Yanfei An · 1 shared paper, 2026 · strength 0.23
  7. Wenhui Lou · 1 shared paper, 2026 · strength 0.23
  8. Liang Liu · 1 shared paper, 2026 · strength 0.23
  9. Yun Jin · 1 shared paper, 2026 · strength 0.23
  10. Wenchuan Wu · 1 shared paper, 2026 · strength 0.23
  11. LU Hai-yan · 1 shared paper, 2023 · strength 0.17
  12. Yanqing Liu · 1 shared paper, 2023 · strength 0.17
  13. Zhengfei He · 1 shared paper, 2023 · strength 0.17
  14. Chengfei Hao · 1 shared paper, 2018 · strength 0.09
  15. Jianheng Bao · 1 shared paper, 2018 · strength 0.09
  16. Xibo Zhang · 1 shared paper, 2018 · strength 0.09
  17. Zhonglian Li · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.